2016

1. Morita T, Shima Y, Wing JB, Sakaguchi S, Ogata A, Kumanogoh A.
   The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis.
   PLoS One. 2016 Sep 13;11(9):e0162306.
   
2. Fujimoto K, Kinoshita M, Tanaka H, Okuzaki D, Shimada Y, Kayama H, Okumura R, Furuta Y, Narazaki M, Tamura A, Hatakeyama S, Ikawa M, Tsuchiya K, Watanabe M, Kumanogoh A, Tsukita S, Takeda K.
   Regulation of intestinal homeostasis by the ulcerative colitis-associated gene RNF186.
   Mucosal Immunol.2016 Jul 6. doi: 10.1038/mi.2016.58.
   
3. Maeda Y, Kurakawa T, Umemoto E, Motooka D, Ito Y, Gotoh K, Hirota K, Matsushita M, Furuta Y, Narazaki M, Sakaguchi N, Kayama H, Nakamura S, Iida T, Saeki Y, Kumanogoh A, Sakaguchi S, Takeda K.
   Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine.
   Arthritis Rheumatol.2016 Jun 22. doi: 10.1002/art.39783.
   
4. Suzuki K, Tsunoda H, Omiya R, Matoba K, Baba T, Suzuki S, Segawa H, Kumanogoh A, Iwasaki K, Hattori K, Takagi J.
   Structure of the Plexin Ectodomain Bound by Semaphorin-Mimicking Antibodies.
   PLoS One.2016 Jun 3;11(6):e0156719.
   
5. Morimoto K, Baba Y, Shinohara H, Kang S, Nojima S, Kimura T, Ito D, Yoshida Y, Maeda Y, Sarashina-Kida H, Nishide M, Hosokawa T, Kato Y, Hayama Y, Kinehara Y, Okuno T, Takamatsu H, Hirano T, Shima Y, Narazaki M, Kurosaki T, Toyofuku T, Kumanogoh A.
   LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activation.
   Sci Rep. 2016 May 11;6:25738.
   
6. Ohmi Y, Ise W, Harazono A, Takakura D, Fukuyama H, Baba Y, Narazaki M, Shoda H, Takahashi N, Ohkawa Y, Ji S, Sugiyama F, Fujio K, Kumanogoh A, Yamamoto K, Kawasaki N, Kurosaki T, Takahashi Y, Furukawa K.
   Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis.
   Nat Commun.2016 Apr 5;7:11205. 8.
   
7. Hasegawa K, Tanaka S, Fujiki F, Morimoto S, Nakano K, Kinoshita H, Okumura A, Fujioka Y, Urakawa R, Nakajima H, Tatsumi N, Nakata J, Takashima S, Nishida S, Tsuboi A, Oka Y, Oji Y, Miyoshi E, Hirata T, Kumanogoh A, Sugiyama H, Hosen N.
   Glycosylation Status of CD43 Protein Is Associated with Resistance of Leukemia Cells to CTL-Mediated Cytolysis.
   PLoS One. 2016 Mar 24;11(3):e0152326.
   

   2015

8. Ito D, Nojima S, Nishide M, Okuno T, Takamatsu H, Kang S, Kimura T, Yoshida Y, Morimoto K, Maeda Y, Hosokawa T, Toyofuku T, Ohshima J, Kamimura D, Yamamoto M, Murakami M, Morii E, Rakugi H, Isaka Y, Kumanogoh A.
   mTOR Complex Signaling through the SEMA4A-Plexin B2 Axis Is Required for Optimal Activation and Differentiation of CD8+ T Cells.
   J Immunol. 2015 Aug 1;195(3):934-43.
   
9. Toyofuku T, Morimoto K, Sasawatari S, Kumanogoh A.
   Leucine-Rich Repeat Kinase 1 Regulates Autophagy through Turning On TBC1D2-Dependent Rab7 Inactivation.
   Mol Cell Biol. 2015 Sep 1;35(17):3044-58.
   
10. Yoshida Y, Ogata A, Kang S, Ebina K, Shi K, Nojima S, Kimura T, Ito D, Morimoto K, Nishide M, Hosokawa T, Hirano T, Shima Y, Narazaki M, Tsuboi H, Saeki Y, Tomita T, Tanaka T, Kumanogoh A.
    Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications.
    Arthritis Rheumatol. 2015 Jun;67(6):1481-90.
    

2014

1. Tamaki S, Mano T, Sakata Y, Ohtani T, Takeda Y, Kamimura D, Omori Y, Tsukamoto Y, Ikeya Y, Kawai M, Kumanogoh A, Hagihara K, Ishii R, Higashimori M, Kaneko M, Hasuwa H, Miwa T, Yamamoto K, Komuro I.
   Koda T, Okuno T, Takata K, Honorat JA, Kinoshita M, Tada S, Moriya M, Sakoda S, Mochizuki H, Kumanogoh A, Nakatsuji Y.
   J Neuroimmunol. 2014 Mar 15;268(1-2):43-9.
   
2. Tamaki S, Mano T, Sakata Y, Ohtani T, Takeda Y, Kamimura D, Omori Y, Tsukamoto Y, Ikeya Y, Kawai M, Kumanogoh A, Hagihara K, Ishii R, Higashimori M, Kaneko M, Hasuwa H, Miwa T, Yamamoto K, Komuro I.
   Koda T, Okuno T, Takata K, Honorat JA, Kinoshita M, Tada S, Moriya M, Sakoda S, Mochizuki H, Kumanogoh A, Nakatsuji Y.
   J Neuroimmunol. 2014 Mar 15;268(1-2):43-9.
   

2013

1. Kumanogoh A, Kikutani H.
   Immunological functions of the neuropilins and plexins as receptors for semaphorins.
   Nat Rev Immunol. 2013 Nov;13(11):802-14. Review.
   
2. Ogawa M, Matsuda T, Ogata A, Hamasaki T, Kumanogoh A, Toyofuku T, Tanaka T.
   DNA damage in rheumatoid arthritis: an age-dependent increase in the lipid peroxidation-derived DNA adduct, heptanone-etheno-2'-deoxycytidine.
   Autoimmune Dis. 2013:183487.
   
3. Jin Y, Tachibana I, Takeda Y, He P, Kang S, Suzuki M, Kuhara H, Tetsumoto S, Tsujino K, Minami T, Iwasaki T, Nakanishi K, Kohmo S, Hirata H, Takahashi R, Inoue K, Nagatomo I, Kida H, Kijima T, Ito M, Saya H, Kumanogoh A.
   Statins decrease lung inflammation in mice by upregulating tetraspanin CD9 in macrophages.
   PLoS One. 2013 Sep 9;8(9):e73706.
   
4. Minami T, Kijima T, Kohmo S, Arase H, Otani Y, Nagatomo I, Takahashi R, Miyake K, Higashiguchi M, Morimura O, Ihara S, Tsujino K, Hirata H, Inoue K, Takeda Y, Kida H, Tachibana I, Kumanogoh A.
   Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis.
   Sci Rep. 2013;3:2669.
   
5. Tamaki S, Mano T, Sakata Y, Ohtani T, Takeda Y, Kamimura D, Omori Y, Tsukamoto Y, Ikeya Y, Kawai M, Kumanogoh A, Hagihara K, Ishii R, Higashimori M, Kaneko M, Hasuwa H, Miwa T, Yamamoto K, Komuro I.
   Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction.
   PLoS One. 2013 Jul 19;8(7):e68893.
   
   
6. He P, Kuhara H, Tachibana I, Jin Y, Takeda Y, Tetsumoto S, Minami T, Kohmo S, Hirata H, Takahashi R, Inoue K, Nagatomo I, Kida H, Kijima T, Naka T, Morii E, Kawase I, Kumanogoh A.
   Calretinin mediates apoptosis in small cell lung cancer cells expressing tetraspanin CD9.
   FEBS Open Bio. 2013 May 10;3:225-30.
   
   
7. Nojima S, Toyofuku T, Kamao H, Ishigami C, Kaneko J, Okuno T, Takamatsu H, Ito D, Kang S, Kimura T, Yoshida Y, Morimoto K, Maeda Y, Ogata A, Ikawa M, Morii E, Aozasa K, Takagi J, Takahashi M, Kumanogoh A.
   A point mutation in Semaphorin 4A associates with defective endosomal sorting and causes retinal degeneration.
   Nat Commun. 2013;4:1406.
   
   
8. Kida H, Ihara S, Kumanogoh A.
   Involvement of STAT3 in immune evasion during lung tumorigenesis.
   Oncoimmunology. 2013 Jan 1;2(1):e22653.
   
   
9. Lin Y, Fujiki F, Katsuhara A, Oka Y, Tsuboi A, Aoyama N, Tanii S, Nakajima H, Tatsumi N, Morimoto S, Tamanaka T, Tachino S, Hosen N, Nishida S, Oji Y, Kumanogoh A, Sugiyama H..
   HLA-DPB1*05: 01-restricted WT1332-specific TCR-transduced CD4+ T lymphocytes display a helper activity for WT1-specific CTL induction and a cytotoxicity against leukemia cells.
   J Immunother. 2013 Apr;36(3):159-70.
   
   
10. Hirata H, Tetsumoto S, Kijima T, Kida H, Kumagai T, Takahashi R, Otani Y, Inoue K, Kuhara H, Shimada K, Nagatomo I, Takeda Y, Goya S, Yoshizaki K, Kawase I, Tachibana I, Kishimoto T, Kumanogoh A..
    Favorable responses to tocilizumab in two patients with cancer-related cachexia.
    J Pain Symptom Manage. 2013 Aug;46(2):e9-e13.
    
    
11. Takimoto T, Kijima T, Otani Y, Nonen S, Namba Y, Mori M, Yokota S, Minami S, Komuta K, Uchida J, Imamura F, Furukawa M, Tsuruta N, Fujio Y, Azuma J, Tachibana I, Kumanogoh A..
    Polymorphisms of CYP2D6 gene and gefitinib-induced hepatotoxicity.
    Clin Lung Cancer. 2013 Sep;14(5):502-7.
    
    
12. Tetsumoto S, Takeda Y, Imai H, Kimura A, Jin Y, Nakanishi K, Maeda Y, Kuhara H, Tsujino K, Iwasaki T, Shigeta H, Kondo Y, Ito M, Minami T, Hirata H, Takahashi R, Kohmo S, Nagatomo I, Inoue K, Kida H, Kijima T, Tachibana I, Maeda N, Funahashi T, Shimomura I, Fujiwara H, Kumanogoh A..
    Validation of noninvasive morphological and diffusion imaging in mouse emphysema by micro-computed tomography and hyperpolarized (129)Xe magnetic resonance imaging.
    Am J Respir Cell Mol Biol. 2013 Oct;49(4):592-600.
    
    
13. Nishijima Y, Hirata H, Himeno A, Kida H, Matsumoto M, Takahashi R, Otani Y, Inoue K, Nagatomo I, Takeda Y, Kijima T, Tachibana I, Fujimura Y, Kumanogoh A..
    Drug-induced thrombotic thrombocytopenic purpura successfully treated with recombinant human soluble thrombomodulin.
    Intern Med. 2013;52(10):1111-4.
    
    

2012

1. Kikuta J, Wada Y, Kowada T, Wang Z, Sun-Wada GH, Nishiyama I, Mizukami S, Maiya N, Yasuda H, Kumanogoh A, Kikuchi K, Germain RN, Ishii M.
   Dynamic visualization of RANKL and Th17-mediated osteoclast function.
   J Clin Invest. (in press)
   
   
2. Tachino S, Fujiki F, Oka Y, Tsuboi A, Morimoto S, Lin YH, Tamanaka T, Kondo K, Nakajima H, Nishida S, Hosen N, Oji Y, Kumanogoh A, Sugiyama H.
   Functional human Th17 clones with WT1-specific helper activity.
   Cancer Immunol Immunother. (in press)
   
   
3. Tamanaka T, Oka Y, Fujiki F, Tsuboi A, Katsuhara A, Nakajima H, Hosen N, Nishida S, Lin YH, Tachino S, Akatsuka Y, Kuzushima K, Oji Y, Kumanogoh A, Sugiyama H.
   Recognition of a Natural WT1 Epitope by a Modified WT1 Peptide-specific T-Cell Receptor.
   Anticancer Res. 32(12):5201-9. 2012.
   
   
4. Iwasaki T, Takeda Y, Maruyama K, Yokosaki Y, Tsujino K, Tetsumoto S, Kuhara H, Nakanishi K, Otani Y, Jin Y, Kohmo S, Hirata H, Takahashi R, Suzuki M, Inoue K, Nagatomo I, Goya S, Kijima T, Kumagai T, Tachibana I, Kawase I,Kumanogoh A.
   Deletion of tetraspanin CD9 diminishes lymphangiogenesis in vivo and in vitro.
   J Biol Chem. (in press)
   
   
5. Ogata A,Kumanogoh A and Tanaka T.
   Pathological role of interleukin-6 in psoriatic arthritis.
   Arthritis (in press)
   
   
6. Takeda Y, Nakanishi K, Tachibana I, Kumanogoh A.
   Adiponectin: A Novel Link Between Adipocytes and COPD.
   Vitam Horm. 90:419-35. 2012.
   
   
7. Morihana T, Goya S, Mizui M, Yasui T, Prasad DV, Kumanogoh A, Tamura M, Shikina T, Maeda Y, Iwamoto Y, Inohara H, Kikutani H.
   An Inhibitory Role for Sema4A in Antigen-Specific Allergic Asthma.
   J Clin Immunol. (in press)
   
   
8. Otani Y, Kijima T, Kohmo S, Oishi S, Minami T, Nagatomo I, Takahashi R, Hirata H, Suzuki M, Inoue K, Takeda Y, Kida H, Tachibana I, Fujii N, Kumanogoh A.
   Suppression of metastases of small cell lung cancer cells in mice by a peptidic CXCR4 inhibitor TF14016.
   FEBS Lett. (in press)
   
   
9. Shiroyama T, Kijima T, Komuta K, Yamamoto S, Minami S, Ogata Y, Okafuji K, Imamura F, Hirashima T, Tachibana I, Kawase I, Kumanogoh A.
   Phase II tailored S-1 regimen study of first-line chemotherapy in elderly patients with advanced and recurrent non-small cell lung cancer.
   Cancer Chemother Pharmacol. (in press)
   
   
10. Kang S and Kumanogoh A.
    Semaphorins in bone development, homeostasis, and disease.
    Semin Cell Dev Biol. (in press)
    
    
11. Witherden DA, Watanabe M, Garijo O, Rieder SE, Sarkisyan G, Cronin SJ, Verdino P, Wilson IA, Kumanogoh A, Kikutani H, Teyton L, Fischer WH, Havran WL.
    The CD100 Receptor Interacts with Its Plexin B2 Ligand to Regulate Epidermal γδ T Cell Function.
    Immunity.37:314-25. 2012.
    
    
12. Kurosaki T, Saito T, Kumanogoh A, Takeda K, Kaisho T.
    Dynamism of immune reactions and regulation.
    Int Immunol. 24:473-5. 2012.
    
    
13. Toyofuku T, Nojima S, Ishikawa T, Takamatsu T, Tsujimura T, Uemura A, Matsuda J, Seki T, Kumanogoh A.
    Endosomal sorting by Semaphorin 4A in retinal pigment epithelium supports photoreceptor survival.
    Genes Dev. 26:816-29. 2012.
    
    
14. Hayashi M, Nakashima T, Taniguchi M, Kodama T,Kumanogoh A, Takayanagi H.
    Osteoprotection by Semaphorin 3A.
    Nature (Article) 485:69-74.2012.
    
    
15. Nakatsuji Y, Okuno T, Moriya M, Sugimoto T, Kinoshita M, Takamatsu H, Nojima S, Kimura T, Kang S, Ito D, Nakagawa Y, Toyofuku T, Takata K, Nakano M, Kubo M, Suzuki S, Matsui-Hasumi A, Uto-Konomi A, Ogata A, Mochizuki H, Sakoda S, and Kumanogoh A.
    Elevation of Sema4A implicates T helper cell skewing and the efficacy of interferon-β therapy in multiple sclerosis.
    J.Immunol. 188:4858-65.2012.
    
    
16. Hosen N, Matsuoka Y, Kishida S, Nakata J, Mizutani Y, Hasegawa K, Mugitani A, Ichihara H, Aoyama Y, Nishida S, Tsuboi A, Fujiki F, Tatsumi N, Nakajima H, Hino M, Kimura T, Yata K, Abe M, Oka Y, Oji Y, Kumanogoh A, Sugiyama H.
    CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients.
    Leukemia. 26:2135-41. 2012.
    
    
17. Tsujino K, Takeda Y, Arai T, Shintani Y, Inagaki R, Saiga H, Iwasaki T, Tetsumoto S, Jin Y, Ihara S, Minami T, Suzuki M, Nagatomo I, Inoue K, Kida H, Kijima T, Ito M, Kitaichi M, Inoue Y, Tachibana I, Takeda K, Okumura M, Hemler ME, Kumanogoh A.
    Tetraspanin CD151 protects against pulmonary fibrosis by maintaining epithelial integrity.
    Am J Respir Crit Care Med. 186:170-80.2012.
    
    
18. Minami T, Kijima T, Otani Y, Kohmo S, Takahashi R, Nagatomo I, Hirata H, Suzuki M, Inoue K, Takeda Y, Kida H, Tachibana I, Kumanogoh A.
    HER2 As Therapeutic Target for Overcoming ATP-Binding Cassette Transporter-Mediated Chemoresistance in Small Cell Lung Cancer.
    Mol Cancer Ther. 11:830-41.2012.
    
    
19. Ihara S, Kida H, Arase H, Tripathi LP, Chen Y-A, Yoshida M, Kashiwa Y, Hirata H, Fukamizu R, Inoue R, Goya S, Takahashi R, Minami T, Tsujino K, Suzuki M, Kohmo S, Inoue K, Nagatomo I, Takeda Y, Kijima T, Mizuguchi K, Tachibana I, Kumanogoh A.
    Inhibitory roles of signal transducer and activator of transcription 3 in anti-tumor immunity during carcinogen-induced lung tumorigenesis.
    Cancer Res. 72:2990-9. 2012.
    
    
20. Kuwajima T, Yoshida Y, Takegahara N,Kumanogoh A, Petros Tj, Jessell TM, Sakurai T, Mason C.
    Optic chiasm presentation of Semaphorin6D in the context of Plexin-A1 and Nr-CAM promotes retinal axon midline crossing.
    Neuron 33:127-35. 2012.
    
    
21. Takamatsu H, Kumanogoh A.
    Diverse roles of semaphorin-plexin signaling in the immune system.
    Trends Immunol. 33:127-35. 2012.
    
    
22. Kang S, Okuno T, Takegahara N, Takamatsu H, Nojima S, Kimura T, Yoshida Y, Ito D, Ohmae S, You DJ, Toyofuku T, Jang MH, Kumanogoh A
    Intestinal epithelial cell-derived semaphorin 7A negatively regulates development of colitis via αvβ1 integrin.
    J. Immunol. 188:1108-16.2012
    
    
23. Morimoto S, Oka Y, Tsuboi A, Tanaka Y, Fujiki F, Nakajima H, Hosen N, Nishida S, Nakata J, Nakae Y, Maruno M, Myoui A, Enomoto T, Izumoto S, Sekimoto M, Kagawa N, Hashimoto N, Yoshimine T, Oji Y, Kumanogoh A, Sugiyama H.
    Biased usage of T cell receptor β-chain variable region genes of Wilms' tumor gene (WT1)-specific CD8(+) T cells in patients with solid tumors and healthy donors.
    Cancer Sci. 103:408-414. 2012.
    
    
24. Takahashi R, Hirata H, Tachibana I, Shimosegawa E, Inoue A, Nagatomo I, Takeda Y, Kida H, Goya S, Kijima T, Yoshida M, Kumagai T, Kumanogoh A, Okumura M, Hatazawa J, Kawase I
    Early [18F]fluorodeoxyglucose positron emission tomography at two days of gefitinib treatment predicts clinical outcome in patients with adenocarcinoma of the lung.
    Clin Cancer Res. 18:220-8. 2012
    
    
25. Ogata A, Umegaki N, Katayama I, Kumanogoh A, Tanaka T
    Psoriatic arthritis in two patients with an inadequate response to treatment with tocilizumab.
    Joint Bone Spine. 79:85-7. 2012
    

2011

1. Muramatsu R, Kubo T, Mori M, Nakamura Y, Fujita Y, Akutsu T, Okuno T, Taniguchi J, Kumanogoh A, Yoshida M, Mochizuki H, Kuwabara S, Yamashita T.
   RGMa modulates T cell responses and is involved in autoimmune encephalomyelitis.
   Nat Med. 2011 Mar 20. [Epub ahead of print]
   
   
2. Okuno T, Nakatsuji Y, Kumanogoh A.
   The role of immune semaphorins in multiple sclerosis.
   FEBS Lett. 2011 Mar 21.[Epub ahead of print]
   
   
3. Zhao H, Maruyama T, Hattori Y, Sugo N, Takamatsu H, Kumanogoh A, Shirasaki R, Yamamoto N.
   A molecular mechanism that regulates medially oriented axonal growth of upper layer neurons in the developing neocortex.
   J Comp Neurol. 2011 Apr 1;519(5):834-48.
   
   
4. Nakagawa Y, Takamatsu H, Okuno T, Kang S, Nojima S, Kimura T, Kataoka TR, Ikawa M, Toyofuku T, Katayama I, Kumanogoh A.
   Identification of semaphorin 4B as a negative regulator of basophil-mediated immune responses.
   J. Immunol. 2011 Mar 1;186(5):2881-8.
   
   
5. Maier V, Jolicoeur C, Rayburn H, Takegahara N, Kumanogoh A, Kikutani H, Tessier-Lavigne M, Wurst W, Friedel RH.
   Semaphorin 4C and 4G are ligands of Plexin-B2 required in cerebellar development.
   Mol Cell Neurosci. 13: 621-631, 2000
   

2010

1. Ishii H, Kubo T, Kumanogoh A, Yamashita T.
   Th1 cells promote neurite outgrowth from cortical neurons via a mechanism dependent on semaphorins.
   Biochem Biophys Res Commun. 2010 Nov 5;402(1):168-72.
   
   
2. Nogi T, Yasui N, Mihara E, Matsunaga Y, Noda M, Yamashita N, Toyofuku T, Uchiyama S, Goshima Y, Kumanogoh A, Takagi J.
   Structural basis for semaphorin signalling through the plexin receptor.
   Nature. 2010 Sep 29. [Epub ahead of print]
   
   
3. Ch'ng ES, Kumanogoh A.
   Roles of Sema4D and Plexin-B1 in tumor progression.
   Mol Cancer. 2010 Sep 21;9(1):251. [Epub ahead of print]
   
   
4. Wannemacher KM, Zhu L, Jiang H, Fong KP, Stalker TJ, Lee D, Tran AN, Neeves KB, Maloney S, Kumanogoh A, Kikutani H, Hammer DA, Diamond SL, Brass LF.
   Diminished contact-dependent reinforcement of Syk activation underlies impaired thrombus growth in mice lacking Semaphorin 4D.
   Blood. 2010 Sep 20. [Epub ahead of print]
   
   
5. Takegahara N, Kang S, Nojima S, Takamatsu H, Okuno T, Kikutani H, Toyofuku T, Kumanogoh A.
   Integral roles of a guanine nucleotide exchange factor, FARP2, in osteoclast podosome rearrangements.
   FASEB J. 2010 Aug 11. [Epub ahead of print]
   
   
6. Kumanogoh A, Kikutani H.
   Semaphorins and their receptors: novel features of neural guidance molecules.
   Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(6):611-20.
   
   
7. Yukawa K, Tanaka T, Kishino M, Yoshida K, Takeuchi N, Ito T, Takamatsu H, Kikutani H, Kumanogoh A.
   Deletion of Sema4D gene reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.
   Int J Mol Med. 2010 Jul;26(1):39-44.
   
   
8. Takamatsu H, Takegahara N, Nakagawa Y, Tomura M, Taniguchi M, Friedel RH, Rayburn H, Tessier-Lavigne M, Yoshida Y, Okuno T, Mizui M, Kang S, Nojima S, Tsujimura T, Nakatsuji Y, Katayama I, Toyofuku T, Kikutani H, Kumanogoh A.
   Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II.
   Nat Immunol. 11: 594-600, 2010.
   
   
9. Yukawa K, Tanaka T, Kishino M, Yoshida K, Takeuchi N, Ito T, Takamatsu H, Kikutani H, Kumanogoh A.
   Deletion of Sema4D gene reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.
   Int J Mol Med. 26:39-44.2010.
   
   
10. Kumanogoh A, Ogata M.
    The study of cytokines by Japanese researchers: a historical perspective.
    Int Immunol. 22:341-5. 2010.
    
    
11. Kinoshita M., Y. Nakatsuji, T. Kimura, M. Moriya, K. Takata, T. Okuno,
    A. Kumanogoh, K. Kajiyama, H. Yoshikawa, S. Sakoda
    Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cell.
    Biochem Biophys Res Commun. 394:205-10. 2010.
    
    
12. Nawabi H, A. Briancon-Marjollet, C. Clark, I. Sanyas, H. Takamatsu, T. Okuno, A. Kumanogoh, M. BozonM, K. Takeshima, Y. Yoshida, F. Moret, K. Abouzid, V. Castellani.
    A midline switch of receptor processing regulates commissural axon guidance in vertebrates.
    Genes Dev. 24:396-410,2010
    
    
13. Okuno T., Y. Nakatsuji, M. Moriya , H. Takamatsu, S. Nojima, N. Takegahara , T. Toyofuku, Y. Nakagawa, S. Kang, RH. Friedel, S. Sakoda, K. Kikutani and A. Kumanogoh.
    Involvement of Sema4D-Plexin-B1 interactions in the CNS for pathogenesis of experimental autoimmune encephalomyelitis.
    J. Immunol. 184: 1499-1506, 2010.
    
    
14. Kataoka T, A. Kumanogoh, G. Bandara, D. Metcalfe, and A. Gilfillan.
    CD72 negatively regulates KIT-mediated responses in human mast cells.
    J. Immunol. 184:2468-2475.2010
    
    
15. Takamatsu H, Okuno T, and A. Kumanogoh.
    Regulation of immune cell responses by semaphorins and their receptors.
    Cell. Mol. Immunol. 7:83-8. 2010.
    
    
16. Yukawa K, T. Tanaka, K. Yoshida, N. Takeuchi, T. Ito, H. Takamatsu, H. Kikutani, A. Kumanogoh.
    Sema4A induces cell morphological changes through B-type plexin-mediated signaling.
    Int J Mol Med. 25:225-30. 2010.
    
    
17. Takegahara N and A. Kumanogoh
    Involvement of semaphorins in neurological diseases.
    Clinical Exp. Neuroimmunol. 1: 33-45, 2010
    
    

2009

1. Zhu L., T.J.Stalker, K.P.Fong, H.Jiang, A.Tran, I.Crichton, E.K.Lee, K.B.Neeves, S.F.Maloney, H.Kikutani, A.Kumanogoh, E.Pure, S.L.Diamond, L.F.Brass.
   Disruption of SEMA4D ameliorates platelet hypersensitibity in dyslipidemia and confers protection against the development of atherosclerosis.
   Arterioscler Thromb Vasc Biol. Epub ahead of print
   
   
2. Kinoshita M., Y.Nakatsuji, M.Moriya, T.Okuno, A.Kumanogoh, M.Nakano, T.Takahashi, K.Fujihara, K.Tanaka, S.Sakoda.
   Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum.
   Neuroreport. 20:508-512,2009
   
   
3. Inui M., Y.Kikuchi, N.Aoki, S.Endo, T.Maeda, A.Sugahara-Tobinai, S.Fujimura, A.Nakamura, A.Kumanogoh, M.Colonna, T.Takai.
   Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12.
   Proc Natl Acad Sci USA. 06:4816-4821,2009
   
   
4. Mizui M., A.Kumanogoh, H.Kikutani.
   Immune semaphorins: novel features of neural guidance molecules.
   J Clin Immunol. 29:1-11,2009
   
   
5. Yukawa K, T. Tanaka, N. Takeuchi, H. Iso, L. Li, A. Kohsaka, H. Waki, M. Miyajima, M. Maeda, H. Kikutani, A. Kumanogoh
   Sema4D/CD100 deficiency leads to superior performance in mouse motor behavior.
   Can J Neurol Sci. 36:349-55. 2009.
   
   
6. Li M, KM. O'Sullivan, LK. Jones, C. Lo, T. Semple, A. Kumanogoh, H. Kikutani, SR. Holdsworth, R. Kitching.
   Endogenous CD100 promotes glomerular injury and macrophage recruitment in experimental crescentic glomerulonephritis.
   Immunology 128:114-22. 2009.
   
   
7. Kinoshita M, Y. Nakatsuji, T. Kimura, M. Moriya, K. Takata, T. Okuno, A. Kumanogoh, K. Kajiyama, H. Yoshikawa, S. Sakoda.
   Neuromyelitis optica: Passive transfer to rats by human immunoglobulin.
   Biochem Biophys Res Commun. 386:623-7. 2009.
   
   

2008

1. Makino N., T.Toyofuku, N.Takegahara, H.Takamatsu, T.Okuno, Y.Nakagawa, S.Kang, S.Nojima, M.Hori,H.Kikutani, A.Kumanogoh.
   Involvment of Sema4A in the progressiono f experimental autoimmune myocarditis.
   FEBS Lett. 582:3935-3940,2008
   
   
2. Schwarz Q., K.E.Waimey , M.Golding , H.Takamatsu, A.Kumanogoh, H.Fujisawa ,H.J.Cheng , C.Ruhrberg.
   Plexin A3 and plexin A4 convey semaphorin signals during facial nerve development.
   Dev Biol. 324:1-9,2008
   
   
3. Toyofuku T.*(* corresponding author), J.Yoshida , T. Sugimoto , M. Yamamoto , N. Makino , H. Takamatsu , N. Takegahara, F. Suto , M. Hori, H. Fujisawa, A. Kumanogoh*(* corresponding author), H. Kikutani.
   Repulsive and attractive semaphorins cooperate to direct the navigation of cardiac neural crest cells.
   Dev Biol. 321:251-262,2008
   
   
4. Moriya M., Y. Nakatsuji, K. Miyamoto, T. Okuno, M. Kinoshita, A. Kumanogoh, S. Kusunoki, S. Sakoda
   Edaravone, a free radical scavenger, ameliorates experimental autoimmune encephalomyelitis.
   Neurosci Lett. 440: 323-326, 2008
   
   
5. Sierra JR., S. Corso, L. Caione, V. Cepero, P.Conrotto, A. Cignetti, W. Piacibello, A. Kumanogoh, H. Kikutani. PM.Comoglio, L. Tamagnone, S. Giordano.
   Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophpages.
   J Exp Med. 205: 1670-1685, 2008
   
   
6. Mizui M., T. Shikina, H. Arase, K Suzuki, T. Yasui, PD. Rennert, A. Kumanogoh*(* corresponding author), H. Kikutani.
   Bimodal regulation of T cell-mediated immune responses by TIM-4.
   Int Immunol. 20: 695-708, 2008
   
   
7. Suzuki K., A. Kumanogoh, H. Kikutani.
   Semaphorins and their receptors in immune cell interactions.
   Nat Immunol. 9: 17-23, 2008
   
   
8. Yamamoto M., K. Suzuki, T. Okuno, T. Ogata, N. Takegahara, H. Takamatsu, M. Mizui, M. Taniguchi, A. Che´dotal, F. Suto, H. Fujisawa, A. Kumanogoh* (* corresponding author) and H. Kikutani.
   Plexin-A4 negatively regulates T lymphocyte responses.
   Int Immunol. 20: 413-20, 2008
   

2007

1. Watanabe N., M. Tanaka, K. Suzuki, A. Kumanogoh, H. Kikutani, A. Miyajima.
   Tim2 is expressed in mouse fetal hepatocytes and regulates their differentiation.
   Hepatology. 45: 1240-9, 2007
   
   
2. Kikutani H., K. Suzuki, and A. Kumanogoh.
   Immune semaphorins: Increasing members and their diverse roles.
   Adv Immunol. 93: 121-43, 2007
   
   
3. Suzuki K., T. Okuno, M. Yamamoto, R. J. Pasterkamp, N. Takegahara, H. Takamatsu, T. Kitao, J. Takagi, P. D. Rennert, A. L. Kolodkin, A. Kumanogoh*(* corresponding author) and H. Kikutani.
   Semaphorin 7A initiates T cell-mediated inflammatory responses through α1β1 integrin.
   Nature 446: 680-684, 2007
   
   
4. Toyofuku T., M. Yabuki, M. Kamei, M. Kamei, N. Makino, A. Kumanogoh, and M. Hori.
   Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1.
   EMBO J. 26: 1373-84, 2007
   
5. Nakashima H., M. Fujimoto, N. Asashima, R. Watanabe, Y. Kuwano, N. Yazawa, N. Maruyama, H. Okochi, A. Kumanogoh, and K. Tamaki.
   Serum chemokine profile in patients with bullous pemphigoid.
   Br. J. Dermatol. 156: 454-459, 2007
   
6. Zhu L., W. Bergmeier, J. Wu, H. Jiang, T.J. Stalker, M. Cieslak, R. Fan, L. Boumsell, A. Kumanogoh, H. Kikutani, L. Tamagnone, DD. Wagner, ME. Milla, and LF. Brass.
   Regulated surface expression and shedding support a dual role for semaphorins 4D in platelet responses to vascular injury.
   Proc Natl Acad Sci USA. 104: 1621-6, 2007
   
7. Duran-Struuck R, I. Tawara, K. Lowler, S.G. Clouthier, E. Weisiger, C. Rogers, G. Luker, A. Kumanogoh, C. Liu, J.L. Ferrara, P. Reddy.
   A novel role for the semaphorin Sema4D in the induction of allo-responses.
   Biol Blood Marrow Transplant. 13: 1294-1303, 2007
   

2006

1. Takegahara N., H. Takamatsu, T. Toyofuku, T. Tsujimura, T. Okuno, K. Yukawa, M. Mizui, M. Yamamoto, DVR. Prasad, K. Suzuki, M. Ishii, K. Terai, M. Moriya, Y. Nakatsuji, S. Sakoda, S. Sato, S. Akira, K. Takeda, M. Inui, T. Takai, M. Ikawa, M. Okabe, A. Kumanogoh*(* corresponding author) and H. Kikutani.
   Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis.
   Nat Cell Biol. 8: 615-622, 2006
   
2. Li M., Kim M., L.K. O’Sullivan, Jones, T. Semple, A. Kumanogoh, H. Kikutani, S. R. Holdsworth and A. R. Kitching.
   CD100 Enhances Dendritic Cell and CD4+ Cell Activation Leading to Pathogenetic Humoral Responses and Immune Complex Glomerulonephritis.
   J Immunol. 177: 3406-12, 2006
   

2005

1. Toyofuku T., J. Yoshida, T. Sugimoto, H. Zhang, A. Kumanogoh, M. Hori and H. Kikutani.
   The FERM domain containing GEF protein FARP2 triggers signals for Sema3A-mediated axonal repulsion.
   Nat Neurosci. 8: 1712-1719, 2005
   
2. Kumanogoh A., T. Shikina, K. Suzuki, S. Uematsu, K. Yukawa, S. Kashiwamura, H. Tsutsui, M. Yamamoto, H. Takamatsu, EP. Ko-Mitamura, N. Takegahara, S. Marukawa, I. Ishida, H. Morishita, DV Prasad, M. Tamura, M. Mizui, T. Toyofuku, S. Akira, K. Takeda, M. Okabe, and H. Kikutani H.
   Nonredundant roles of Sema4A in the immune system: Defective T cell priming and Th1/Th2 regulation in Sema4A-deficient mice.
   Immunity 22: 305-16, 2005
   
3. Kumanogoh A., T. Shikina, C. Watanabe, N. Takegahara, K. Suzuki, M. Yamamoto, H. Takamatsu, DV. Prasad, M. Mizui, T. Toyofuku, M. Tamura, D. Watanabe, JR. Parnes and H. Kikutani.
   Requirement for CD100-CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartment.
   Int. Immunol. 17: 1277-1282, 2005
   
4. Takegahara N., A. Kumanogoh, and H. Kikutani.
   Semaphorins: a new class of immunoregulatory molecules.
   Philos Trans R Soc Lond B Biol Sci. 360: 1673-80, 2005
   
   
5. Okuno T., Y. Nakatsuji, A. Kumanogoh, M. Moriya, H. Ichinose, H. Sumi, H. Fujimura, H. Kikutani, and S. Sakoda.
   Loss of dopaminergic neurons by the induction of inducible nitric oxide synthase and cyclooxygenase-2 via CD40: Relevance to Parkinson's disease.
   J Neurosci Res. 81: 874-82, 2005
   
6. Yukawa K., T. Tanaka, T. Bai, T. Ueyama, K. Owada-Makabe, Y. Tsubota, M. Maeda, K. Suzuki, H. Kikutani, and A. Kumanogoh.
   Semaphorin 4A induces growth cone collapse of hippocampal neurons in a Rho/Rho-kinase-dependent manner.
   Int J Mol Med. 16: 115-118, 2005
   

2004

1. Toyofuku T., H. Zhang, A. Kumanogoh, N. Takegahara, M. Yabuki, K. Harada, M. Hori, and H. Kikutani.
   Guidance of myocardial patterning in cardiac development by Sema6D reverse signalling.
   Nat Cell Biol. 6: 1204-11, 2004
   
2. Li DH., A. Kumanogoh, TM. Cao, JR. Parnes, and JM. Cullen.
   Woodchuck interleukin-6 gene: structure, characterization, and biologic activity.
   Gene 342: 157-64, 2004
   
3. Okuno T., Y. Nakatsuji, A. Kumanogoh, K. Koguchi, M. Moriya, H. Fujimura, H. Kikutani, and S. Sakoda.
   Induction of cyclooxygenase-2 in reactive glial cells by the CD40 pathway: relevance to amyotrophic lateral sclerosis.
   J Neurochem. 91: 404-12, 2004
   
4. Toyofuku T., H. Zhang, A. Kumanogoh, N. Takegahara, F. Suto, J. Kamei, K. Aoki, M. Yabuki, M. Hori, H. Fujisawa, and H. Kikutani.
   Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-tack and vascular endothelial growth factor receptor type 2.
   Genes Dev. 342: 157-64, 2004
   
5. Kumanogoh A. and H. Kikutani.
   Biological functions and signals of CD100/Sema4D.
   Cell Mol life Sci 61: 292-300, 2004
   

2003

1. Ishida I., A. Kumanogoh*(*equally contribution), K. Suzuki, S. Akahani, K. Noda, and H. Kikutani.
   Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses.
   Int. Immunol. 15: 1027-1034, 2003
   
2. Fauvarque C., A. Kumanogoh, E. Camand, C. Jaillard, G. Barbin, I. Boquet, C. Love, E. Y. Jones, H. Kikutani, C. Lubetzki, I. Dusart and A. Chedotal.
   The transmembrane semaphorin Sema4D/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion.
   J. Neurosci 23: 9229-9239, 2003
   
3. Kumanogoh A. and H. Kikutani.
   Immune semaphorins: a new area of semaphorin research.
   J. Cell Sci, 116: 3463-3470, 2003
   
4. Kumanogoh A. and H. Kikutani.
   Roles of the semaphorin family in immune regulation.
   Adv. Immunol. 81: 173-98, 2003
   
5. H. Kikutani and A. Kumanogoh.
   Semaphorins in T cell-antigen presenting cell interactions.
   Nat. Rev. Immunol. 3: 159-167, 2003
   
6. Suzuki K., A. Kumanogoh and H. Kikutani.
   CD100/Sema4D, a lymphocyte semaphorin involved in the regulation of humoral and cellular immune responses.
   Cytokine Growth Factor Rev. 14: 17-24, 2003
   

2002

1. Kumanogoh A., S. Marukawa, K. Suzuki, N. Takegahara, C. Watanabe, E. Ch’ng, I. Ishida, H. Fujimura, S. Sakoda, K. Yoshida, and H. Kikutani.
   Class IV semaphorin Sema4A enhances T cell activation and interacts with Tim-2.
   Nature 419: 629-633, 2002
   
2. Kumanogoh A., K. Suzuki, E. Ch’ng, C. Watanabe, S. Marukawa, N. Takegahara, I. Ishida, T. Sato, S. Habu, K. Yoshida, W. Shi, and H. Kikutani.
   Requirement for the lymphocyte semaphorin CD100, in the induction of antigen-specific T cells and the maturation of dendritic cells.
   J. Immunol. 169: 1175-1181, 2002
   
3. Yasui T., M. Muraoka, Y. Takaoka-Shichijo, I. Ishida, N. Takegahara, J. Uchida, A. Kumanogoh, S. Suematsu, M. Suzuki and H. Kikutani.
   Dissection of B cell differentiation during primary immune responses in mice with altered CD40 signals.
   Int. Immunol. 14: 319-329, 2002
   

2001

1. Watanabe C., A. Kumanogoh*(*equally contribution), W. Shi, K. Suzuki, S. Yamada, M. Okabe, K. Yoshida, and H. Kikutani.
   Enhanced immune responses in transgenic mice expressing a truncated form of the lymphocyte semaphorin CD100/Sema4D.
   J. Immunol. 167: 4321-4328, 2001
   
2. Wang W., A. Kumanogoh* (*equally contribution), C. Watanabe, W. Shi, K. Yoshida and H. Kikutani.
   Functional Soluble CD100/Sema4D Released from Activated Lymphocytes: Possible Role in Normal and Pathological Immune Responses.
   Blood 97: 3498-3504, 2001
   
3. Kumanogoh A., X. Wang, I. Lee, C. Watanabe, M. Kamanaka, W. Shi, K. Yoshida, T. Sato, S. Habu, M. Itoh, N. Sakaguchi, S. Sakaguchi and H. Kikutani.
   Increased T-cell autoreactivity in the absence of CD40-CD40 ligand interactions: A role of CD40 in regulatory T cell development.
   J. Immunol. 166: 353-360, 2001
   
4. Kumanogoh A. and H. Kikutani.
   The CD100-CD72 interactions: a novel mechanism of immune regulation.
   Trends Immunol. (formerly Immunology Today) 22: 670-676, 2001
   
   

2000

1. Shi W., A. Kumanogoh* (*equally contribution), C. Watanabe, J. Uchida, X. Wang, T. Yasui, K. Yukawa, M. Ikawa, M. Okabe, J. R. Parnes, K. Yoshida, and H. Kikutani.
   The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice.
   Immunity 13: 633-642, 2000
   
2. Kumanogoh A., C. Watanabe, I. Lee, X. Wang, W. Shi, H. Araki, H. Hirata, K. Iwahori, J. Uchida, T. Yasui, M. Matsumoto, K. Yoshida, H. Yakura, C. Pan, J. R. Parnes and H. Kikutani.
   Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling.
   Immunity 13: 621-631, 2000
   

日本語総説

1. 奧野龍禎、熊ノ郷淳
   多発性硬化症の発症とSema4D.
   臨床免疫・アレルギー科 53 (5):468-474, 2010.
2. 熊ノ郷淳
   シグナル伝達研究―
   疾患の発症分子メカニズムと実現化する分子標的薬開発
   多発性硬化症へのセマフォリン分子群の関与
   実験医学増刊号 Vol. 125, No. 15, 118-123, 2008
3. 熊ノ郷淳
   私の発見体験記　免疫セマフォリンー思わぬ役者の出現から始まった研究
   実験医学 Vol. 26, No.1, 95-98, 2008
4. 竹ヶ原宜子、熊ノ郷淳
   免疫セマフォリンによる免疫制御
   医学のあゆみ Vol. 224, No. 6, 481-482, 2008
5. 水井理、熊ノ郷淳
   樹状細胞とＴ細胞の相互作用におけるTim分子の役割
   臨床免疫 vol.46, No. 2
6. 高松漂太、熊ノ郷淳
   樹状細胞によるT細胞の活性化とセマフォリン
   臨床免疫 vol. 46, No. 2
7. 水井理、熊ノ郷淳
   Tim, Semaphorin分子とTh1/Th2制御
   臨床免疫 Vol.45, No4, 459-462, 2006
8. 熊ノ郷淳
   セマフォリン　ことばのカルテ
   メディカルトリビューン Vol.39, No8, p38, 2006
9. 熊ノ郷淳
   セマフォリンの免疫制御
   感染症のBird’s-eye view （南山堂）107-116, 2006
10. 鈴木一博、熊ノ郷淳
    免疫系におけるセマフォリン分子
    生化学 vol.78, No2, 141-145, 2006
    
11. 鈴木一博、熊ノ郷淳
    免疫2006 Molecular Medicine臨時増刊号 (in press）
12. 高松漂太、熊ノ郷淳
    セマフォリンと自己免疫
    日本臨床免疫学会会誌 28 (5), 327-332, 2005
    
13. 水井理、熊ノ郷淳
    セマフォリン分子による免疫制御
    日本臨床免疫学会会誌 28 (3), 109-116, 2005
    
14. 山本みどり、熊ノ郷淳
    セマフォリン
    分子細胞治療（先端医学社） vo3, no.4, 85-87, 2004
15. 識名崇、熊ノ郷淳
    Semaphorinによる免疫制御
    別冊・医学のあゆみ（医歯薬出版） 67-70, 2004
16. 熊ノ郷淳
    免疫セマフォリン分子Sema4AによるTim-2を介したT細胞活性化
    免疫2004 Molecular Medicine臨時増刊号 vol.40, p167-174, 2004
17. 熊ノ郷淳
    免疫セマフォリンを介した免疫応答機構の解析
    三共生命科学研究振興財団研究報告集 vol.19, p79-86, 2003
18. 竹が原宣子、熊ノ郷淳
    セマフォリンと免疫応答の制御
    臨床免疫 40 (1), p88-94, 2003
19. 熊ノ郷淳
    免疫セマフォリン分子による免疫応答制御機構
    蛋白・核酸・酵素 12月増刊号 47 (16) p2254-2260, 2002
    
    
20. 丸川聡子、熊ノ郷淳
    樹状細胞の分化成熟とCD100/Sema4D
    臨床免疫 38 (5), p489-494, 2002
21. 竹が原宣子、熊ノ郷淳
    免疫応答におけるリンパ球セマフォリン分子CD100の役割
    臨床アレルギー 38 (3), p292-297, 2002
22. 丸川聡子、熊ノ郷淳
    免疫セマフォリンによる免疫応答制御機構
    アレルギー科 13(6), 512-519, 2002
23. 熊ノ郷淳
    リンパ球セマフォリン分子CD100のCD72を介した免疫応答の制御
    免疫2002 Molecular Medicine臨時増刊号 p114-121, 2002
24. 熊ノ郷淳
    Special review; 免疫セマフォリン
    細胞工学 Vol.21 No.6, p656-661, 2002
25. 鈴木一博、熊ノ郷淳、菊谷仁
    感染・炎症・免疫 p94-95, 2001
26. 熊ノ郷淳
    免疫系におけるセマフォリン分子CD100/SEMA4Dの機能
    免疫2000-2001 Molecular Medicine臨時増刊号 p184-191, 2001
27. 熊ノ郷淳
    リンパ球セマフォリン分子CD100の免疫応答の制御機構
    実験医学 Vol.19, N05 (増刊号), 2001
28. 渡辺知恵、熊ノ郷淳
    CD100分子による共刺激シグナルと作用発現機序
    臨床免疫 36 (3), 359-365, 2001
29. 渡辺知恵、熊ノ郷淳
    CD40とリンパ球セマフォリン分子CD100/SEMA4D
    臨床免疫 33 (3), 378-383, 2000